FEMY Femasys
Femasys earnings company data as of 4:48 AM ET 10/23
- 1 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 13 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 14 Aug | EPS | -1.40 | -1.33 | Beat |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by FEMY's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $134K bought by 5 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Jeffrey Gerald Mifek Chief Clinical-Medical AffairsBuy$10K 3,125 shares at $3.20 New stakeTraded Aug 7 Filed Aug 11
-
John Charles Canning COOBuy$14K 4,375 shares at $3.20 New stakeTraded Aug 7 Filed Aug 11
-
Dov Elefant CFOBuy$50K 15,625 shares at $3.20 New stakeTraded Aug 7 Filed Aug 11
SEC filings
Recent issuer filings from EDGAR, 23 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| 424B3 | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13D | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 1.01,3.02,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 3.03,5.03,9.01 | Filing Doc | |
| 8-K | 7.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 8-K | 5.02,8.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 1.01,3.02,5.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.